Effects of 12-week oral supplementation of Ecklonia cava polyphenols on anthropometric and blood lipid parameters in overweight Korean individuals: A double-blind randomized clinical trial

Phytotherapy Research

Volumn 26, Issue 3, 2012, Pages 363-368

  Shin, Hyeon Cheol ^a   Kim, Seong Ho ^b   Park, Yongju ^b   Lee, Bong Ho ^b   Hwang, Hye Jeong ^a  

^a Botamedi Research Center   (United States)

^b Hanbat National University   (South Korea)

Author keywords

Brown algae; Cholesterol; Dyslipidemia; Ecklonia cava; Overweight; Phlorotannin

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; POLYPHENOL DERIVATIVE;

ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; ECKLONIA CAVA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; OBESITY; RANDOMIZED CONTROLLED TRIAL; SOUTH KOREA; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADMINISTRATION, ORAL; ADULT; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; HEMATOLOGY; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OVERWEIGHT; PHAEOPHYTA; PHYTOTHERAPY; PLANT EXTRACTS; POLYPHENOLS; REPUBLIC OF KOREA; TIME FACTORS; WAIST CIRCUMFERENCE; YOUNG ADULT;

ECKLONIA CAVA; PHAEOPHYCEAE;

EID: 84858009034     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3559     Document Type: Article

References (27)

1. Arhan M, Oztürk HS, Turhan N et al. 2009. Hepatic oxidant/antioxidant status in cholesterol-fed rabbits: Effects of garlic extract. Hepatol Res 39: 70-77.
2. Artan M, Li Y, Karadeniz F, Lee SH, Kim MM, Kim SK. 2008. Anti-HIV-1 activity of phloroglucinol derivative, 6,6′-bieckol, from Ecklonia cava. Bioorg Med Chem 16: 7921-7926.
3. Brown AL, Lane J, Coverly J et al. 2009. Effects of dietary supplementation with the green tea polyphenol epigallocatechin- 3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr 101: 886-894.
4. Davison K, Coates AM, Buckley JD, Howe PR. 2008. Effect of cocoa flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes (Lond) 32: 1289-1296.
5. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. 2007. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 137: 2405-2411. (Pubitemid 350058708)
6. 2-mcroblobulin from the brown alga Ecklonia kurome OKAMURA. Chem Lett 739-742.
7. Fukuyama Y, Kodama M, Miura I et al. 1989. Anti-plasmin inhibitor. V. Structures of novel dimeric eckols isolated from the brown alga Ecklonia kurome OKAMURA. Chem Pharm Bull 37: 2438-2440. (Pubitemid 19251625)
8. Fukuyama Y, Kodama M, Miura I et al. 1990. Anti-plasmin inhibitor. VI. Structure of phlorofucofuroeckol A, a novel phlorotannin with both dibenzo-1,4-dioxin and dibenzofuran elements, from Ecklonia kurome OKAMURA. Chem Pharm Bull 38: 133-135. (Pubitemid 20138377)
9. Hwang HJ, Chen T, Nines RG, Shin HC, Stoner GD. 2006. Photochemoprevention of UVB-induced skin carcinogenesis in SKH-1 mice by brown algae polyphenols. Int J Cancer 119: 2742-2749. (Pubitemid 44846224)
10. Iwai K. 2008. Antidiabetic and antioxidant effects of polyphenols in brown alga Ecklonia stolonifera in genetically diabetic KK-A(y) mice. Plant Foods Hum Nutr 63: 163-169.
11. Joe MJ, Kim SN, Choi HY et al. 2006. The inhibitory effects of eckol and dieckol from Ecklonia stolonifera on the expression of matrix metalloproteinase-1 in human dermal fibroblasts. Biol Pharm Bull 29: 1735-1739.
12. Jung HA, Hyun SK, Kim HR, Choi JS. 2006. Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera. Fisheries Sci 72: 1292-1299. (Pubitemid 44934883)
13. Kang K, Park Y, Hwang HJ, Kim SH, Lee JG, Shin HC. 2003. Antioxidative properties of brown algae polyphenolics and their perspectives as chemopreventive agents against vascular risk factors. Arch Pharm Res 26: 286-293. (Pubitemid 43080207)
14. Kang KA, Lee KH, Chae S et al. 2005. Eckol isolated from Ecklonia cava attenuates oxidative stress induced cell damage in lung fibroblast cells. FEBS Lett 579: 6295-6304. (Pubitemid 41612143)
15. Kim Y, Suh YK, Choi H. 2004. BMI and metabolic disorders in South Korean adults: 1998 Korea National Health and Nutrition Survey. Obes Res 12: 445-453. (Pubitemid 41132523)
16. Kim YC, An RB, Yoon NY, Nam TJ, Choi JS. 2005. Hepatoprotective constituents of the edible brown alga Ecklonia stolonifera on tacrine-induced cytotoxicity in Hep G2 cells. Arch Pharm Res 28: 1376-1380. (Pubitemid 43042166)
17. Kong CS, Kim JA, Ahn BN, Vo TS, Yoon NY, Kim SK. 2010. 1-(3′,5′-dihydroxyphenoxy)-7-(2″,4″,6-trihydroxyphenoxy) -2,4,9-trihydroxydibenzo-1,4-dioxin inhibits adipocyte differentiation of 3T3-L1 fibroblasts. Mar Biotechnol (NY) 12: 299-307.
18. Lauer RM, Obarzanek E, Hunsberger SA et al. 2000. Efficacy and safety of lowering dietary intake of total fat, saturated fat, and cholesterol in children with elevated LDL cholesterol: the Dietary Intervention Study in Children. Am J Clin Nutr 72: 1332S-1342S.
19. Liu L, Ikeda K, Chen M et al. 2004. Obesity, emerging risk in China: trend of increasing prevalence of obesity and its association with hypertension and hypercholesterolaemia among the Chinese. Clin Exp Pharmacol Physiol 31: S8-S10.
20. Nagao T, Hase T, Tokimitsu I. 2007. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 15: 1473-1483. (Pubitemid 47110911)
21. Nagayama K, Iwamura Y, Shibata T, Hirayama I, Nakamura T. 2002. Bactericidal activity of phlorotannins from the brown alga Ecklonia kurome. J Antimicrob Chemother 50: 889-893. (Pubitemid 36032809)
22. Nakamura Y, Turin TC, Kita Y et al. 2007. Associations of obesity measures with metabolic risk factors in a community-based population in Japan. Circ J 71: 776-781. (Pubitemid 46691059)
23. Pedersen TR, Tobert JA. 2004. Simvastatin: a review. Expert Opin Pharmacother 5: 2583-2596. (Pubitemid 39646520)
24. Shin HC, Hwang HJ, Kang KJ, Lee BH. 2006. An antioxidative and antiinflammatory agent for potential treatment of osteoarthritis from Ecklonia cava. Arch Pharm Res 29: 165-171. (Pubitemid 43352466)
25. Shoelson SE, Herrero L, Naaz A. 2007. Obesity, inflammation, and insulin resistance. Gastroenterology 132: 2169-2180. (Pubitemid 46693756)
26. Smith SC Jr, Blair SN, Bonow RO et al. 2001. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 104: 1577-1579. (Pubitemid 32917355)
27. Yoon NA, Kim HR, Chung HY, Choi JS. 2008. Anti-hyperlipidemic effect of an edible brown algae, Ecklonia stolonifera, and its constituents on poloxamer 407-induced hyperlipidemic and cholesterol-fed rats. Arch Pharm Res 31: 1564-1571.